Published October 18, 2022 | Version v.1
Journal article Open

Case report: Acute toxic myocardial damage caused by 5-fluorouracil—from enigma to success.

  • 1. Department of Cardiology, Emergency Center, University Clinical Center of Serbia, Belgrade, Serbia
  • 2. Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
  • 3. Department of Cardiology, University Clinical Center of Serbia, Belgrade, Serbia
  • 4. Center for Radiology and Magnetic Resonance, University Clinical Center of Serbia, Belgrade, Serbia

Description

Abstract. Considering the pandemic of both cardiovascular diseases and oncological diseases, there is an increasing need for the use of chemotherapy, which through various pathophysiological mechanisms leads to damage to heart function. Cardio toxicity of chemotherapy drugs can manifest itself in a variety of clinical manifestations, which is why establishing a valid diagnosis is a real mystery for clinicians. Acute systolic heart failure (AHF) due to the use of 5-fluorouracil (5-FU) is a rare occurrence if it is not associated with myocardial infarction, myocarditis or Takotsubo cardiomyopathy. Therefore, we decided to present a case of an 52-year-old male who was diagnosed with stage IV RAS wild-type adenocarcinoma of the rectum and in whom the direct toxic effect 5-FU is the main reason for the appearance of toxic cardiomyopathy.

Files

. Case report. Acute toxic myocardial damage ....fcvm-09-991886.pdf

Files (1.2 MB)

Additional details

Related works

Has part
36330002 (PMID)
Is derived from
https://www.frontiersin.org/articles/10.3389/fcvm.2022.991886/full (URL)
Is identical to
PMC9622946 (pmcid)
Is part of
2297-055X (ISSN)
Is supplemented by
frontiersin.org/articles/10.3389/fcvm.2022.991886/full#supplementary-material (Handle)